Metabolic Syndrome Risk Associated with Atypical Antipsychotic Medication: A Case Report

People with schizophrenia are vulnerable group suffer from metabolic syndrome events. Atypical antipsychotics associated weight gain, insulin resistance, and profile lipid abnormalities. The present case was 32-year-old man outpatient had experienced side effects. Metabolic characterized by central obesity, hyperglicemia, hypertriglyceridemia, low High Density Lipoprotein (HDL) cholesterol level, several months feel an increase in appetite. events might be long-term atypical consuming tobacco use. As pharmacists, We advised the patient to referral primary healthcare service for managing Pharmacists intervention through education screening program have positive impacts on lifestyle modification such as decreasing number of cigarette consumption caffeine intake, also increasing physical activity.
 Keywords: Antipsychotics, antipsychotic, syndrome, Pharmacist, Schizophrenia.